1 | hereditary cancer risk assessment | | | | | | | 4 | 0.56% |
2 | clinical genetic testing | | | | | | | 4 | 0.56% |
3 | research and discovery | | | | | | | 3 | 0.42% |
4 | cancer risk assessment envision® | | | | | | | 2 | 0.28% |
5 | research and clinical trials | | | | | | | 2 | 0.28% |
6 | exome sequencingrare hereditary diseases | | | | | | | 2 | 0.28% |
7 | sequencing disease gene panels | | | | | | | 2 | 0.28% |
8 | disease gene panels clinical | | | | | | | 2 | 0.28% |
9 | gene panels clinical trials | | | | | | | 2 | 0.28% |
10 | clinical exome sequencingrare hereditary | | | | | | | 2 | 0.28% |
11 | identification nutritional genomics additional | | | | | | | 2 | 0.28% |
12 | nutritional genomics additional next | | | | | | | 2 | 0.28% |
13 | carrier screening hearing lossnewborn | | | | | | | 2 | 0.28% |
14 | screening carrier screening hearing | | | | | | | 2 | 0.28% |
15 | prenatal screening carrier screening | | | | | | | 2 | 0.28% |
16 | and clinical trials whole | | | | | | | 2 | 0.28% |
17 | clinical trials whole exome | | | | | | | 2 | 0.28% |
18 | notice of privacy practices | | | | | | | 2 | 0.28% |
19 | exome sequencing targeted panel | | | | | | | 1 | 0.14% |
20 | and nature medicine attesting | | | | | | | 1 | 0.14% |
21 | nature and nature medicine | | | | | | | 1 | 0.14% |
22 | in clinical trials and | | | | | | | 1 | 0.14% |
23 | clinical trials and offers | | | | | | | 1 | 0.14% |
24 | research services for exome | | | | | | | 1 | 0.14% |
25 | services for exome sequencing | | | | | | | 1 | 0.14% |
26 | for exome sequencing targeted | | | | | | | 1 | 0.14% |
27 | including nature and nature | | | | | | | 1 | 0.14% |
28 | journals including nature and | | | | | | | 1 | 0.14% |
29 | in highly reputable biomedical | | | | | | | 1 | 0.14% |
30 | from genetic diagnoses and | | | | | | | 1 | 0.14% |
31 | genetic diagnoses and research | | | | | | | 1 | 0.14% |
32 | publications in highly reputable | | | | | | | 1 | 0.14% |
33 | in publications in highly | | | | | | | 1 | 0.14% |
34 | targeted panel sequencing and | | | | | | | 1 | 0.14% |
35 | rna sequencing results from | | | | | | | 1 | 0.14% |
36 | sequencing results from genetic | | | | | | | 1 | 0.14% |
37 | resulted in publications in | | | | | | | 1 | 0.14% |
38 | otogenetics resulted in publications | | | | | | | 1 | 0.14% |
39 | nature medicine attesting to | | | | | | | 1 | 0.14% |
40 | at otogenetics resulted in | | | | | | | 1 | 0.14% |